Members of the US House of Representatives have approved a bill to expand and streamline research into CBD and cannabis. The bill is now heading for the Senate and is expected to reach president Joe Biden’s desk.

The House considered the Medical Marijuana and Cannabidiol Research Expansion Act under a process known as suspension of the rules, which is generally used to pass non-controversial bills quickly. The bipartisan bill was sponsored by representatives Earl Blumenauer, a Democrat from Oregon, and Maryland Republican Andy Harris and passed on a vote of 325-95.

Read full article
I'm already a subscriber
Author default picture

Lorraine Mullaney

Senior writer
Lorraine is responsible for writing news analysis and assisting with copy-editing. Lorraine is a copywriter and editor who has written and edited words for a wide range of audiences, from local community newspapers to consumer magazines and trade websites.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization